Ex vivo autologous immune cell assay to study modulation of type 2 Inflammation by processed- or novel food extracts in peanut allergy

An ex vivo autologous moDC DC2–T cell–B cell assay in six peanut-allergic patients shows processed peanut proteins modulate type 2 inflammation, with P-DH and P-DHG shifting cytokine profiles.

• Why it matters: Peanut allergy diagnostics focus on allergic endpoints, leaving gaps in measuring how food processing and novel products influence DC2-mediated Th2 polarization and downstream IgE/IgG responses.
• What they did: CD14+ monocytes, CD4+ T cells, and CD19+ B cells from six patients were used to generate IL4/GM-CSF moDCs, expose them to DC2 mix ± peanut samples for 48h, then co-culture with T cells for 5d and B cells for 10d.
• The result: P-D DC2 enhanced IL13 secretion and %Tregs, P-DH favored Th2, and P-DHG increased IFN{gamma} without raising %Treg; all increased CD40L+CD25+ memory Th2 cells.

AI summary of the abstract · may contain errors · not medical advice · read the paper.